BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 12481843)

  • 1. The power issue: determination of KB or Ki from IC50. A closer look at the Cheng-Prusoff equation, the Schild plot and related power equations.
    Cheng HC
    J Pharmacol Toxicol Methods; 2001; 46(2):61-71. PubMed ID: 12481843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of cooperativity on the determination of dissociation constants: examination of the Cheng-Prusoff equation, the Scatchard analysis, the Schild analysis and related power equations.
    Cheng HC
    Pharmacol Res; 2004 Jul; 50(1):21-40. PubMed ID: 15082026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of competitive antagonist affinity by the Schild method and from functional inhibition curves using a novel form of the Gaddum equation.
    Ezechiáš M; Cajthaml T
    Toxicology; 2019 May; 420():21-28. PubMed ID: 30935971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of antagonist Kb from inhibition curves in functional experiments: alternatives to the Cheng-Prusoff equation.
    Lazareno S; Birdsall NJ
    Trends Pharmacol Sci; 1993 Jun; 14(6):237-9. PubMed ID: 8372404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Schild regression in the process of receptor classification.
    Kenakin TP
    Can J Physiol Pharmacol; 1982 Mar; 60(3):249-65. PubMed ID: 7042056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of competitive antagonist affinity from functional inhibition curves using the Gaddum, Schild and Cheng-Prusoff equations.
    Lazareno S; Birdsall NJ
    Br J Pharmacol; 1993 Aug; 109(4):1110-9. PubMed ID: 8401922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cheng-Prusoff relationship: something lost in the translation.
    Craig DA
    Trends Pharmacol Sci; 1993 Mar; 14(3):89-91. PubMed ID: 8488569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of antagonist dose-response curves for estimation of pA2-values by Schild-plot analysis and detection of allosteric interactions.
    Pöch G; Brunner F; Kühberger E
    Br J Pharmacol; 1992 Jul; 106(3):710-6. PubMed ID: 1504755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Problems associated with the application of the Cheng-Prusoff relationship to estimate atropine affinity constants using functional tissue responses.
    Eglen RM; Whiting RL
    Life Sci; 1989; 44(1):81-94. PubMed ID: 2913438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An alternative method to evaluate the nature of an antagonist and its potency: a theoretical approach.
    Calderone V
    J Pharmacol Toxicol Methods; 1998 Apr; 39(3):129-35. PubMed ID: 9741386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
    Ellwood AJ; Curtis MJ
    Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the activity of alpha 1-adrenoceptor antagonists in rat aorta.
    Van der Graaf PH; Shankley NP; Black JW
    Br J Pharmacol; 1996 May; 118(2):299-310. PubMed ID: 8735631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonist inhibition curves and the measurement of dissociation constants.
    Barlow RB; Bond SM; Bream E; Macfarlane L; McQueen DS
    Br J Pharmacol; 1997 Jan; 120(1):13-8. PubMed ID: 9117087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel method for determination of the affinity of protein: protein interactions in homogeneous assays.
    Newton P; Harrison P; Clulow S
    J Biomol Screen; 2008 Aug; 13(7):674-82. PubMed ID: 18626116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental and theoretical comparisons between the classical Schild analysis and a new alternative method to evaluate the pA2 of competitive antagonists.
    Calderone V; Baragatti B; Breschi MC; Martinotti E
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):477-87. PubMed ID: 10598787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding Curve Viewer: Visualizing the Equilibrium and Kinetics of Protein-Ligand Binding and Competitive Binding.
    Du Y
    J Chem Inf Model; 2024 May; 64(10):4180-4192. PubMed ID: 38720179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New methods for determining dissociation constants of agonist-receptor complexes.
    Venter DP
    Eur J Pharmacol; 1996 May; 303(3):235-46. PubMed ID: 8813575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linearization of two ligand-one binding site scatchard plot and the "IC50" competitive inhibition plot: application to the simplified graphical determination of equilibrium constants.
    Gray HE; Luttge WG
    Life Sci; 1988; 42(3):231-7. PubMed ID: 3336278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suramin is a slowly-equilibrating but competitive antagonist at P2x-receptors in the rabbit isolated ear artery.
    Leff P; Wood BE; O'Connor SE
    Br J Pharmacol; 1990 Nov; 101(3):645-9. PubMed ID: 2076483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of drug-receptor affinity measures in the differentiation of receptors.
    Tallarida RJ
    Fed Proc; 1982 May; 41(7):2323-7. PubMed ID: 6122613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.